These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31722413)

  • 1. An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databases.
    Vanier A; Smolen JS; Allaart CF; Van Vollenhoven R; Verschueren P; Vastesaeger N; Saevarsdottir S; Visser K; Aletaha D; Combe B; Fautrel B
    Rheumatology (Oxford); 2020 Aug; 59(8):1842-1852. PubMed ID: 31722413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort.
    Fautrel B; Granger B; Combe B; Saraux A; Guillemin F; Le Loet X
    Arthritis Res Ther; 2012 Nov; 14(6):R249. PubMed ID: 23164197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.
    Vastesaeger N; Xu S; Aletaha D; St Clair EW; Smolen JS
    Rheumatology (Oxford); 2009 Sep; 48(9):1114-21. PubMed ID: 19589891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of matrices in daily clinical practice to predict rapid radiologic progression in patients with early RA.
    De Cock D; Vanderschueren G; Meyfroidt S; Joly J; Van der Elst K; Westhovens R; Verschueren P
    Semin Arthritis Rheum; 2014 Apr; 43(5):627-31. PubMed ID: 24200124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study.
    Visser K; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Ronday HK; Seys PE; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2010 Jul; 69(7):1333-7. PubMed ID: 20498212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?
    Heimans L; Wevers-deBoer KV; Ronday HK; Collée G; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Clin Rheumatol; 2015 Jan; 34(1):163-6. PubMed ID: 25431327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients.
    Végh E; Gaál J; Géher P; Gömöri E; Kovács A; Kovács L; Nagy K; Posta EF; Tamási L; Tóth E; Varga E; Domján A; Szekanecz Z; Szűcs G
    BMC Musculoskelet Disord; 2021 Apr; 22(1):325. PubMed ID: 33794855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial.
    Saevarsdottir S; Rezaei H; Geborek P; Petersson I; Ernestam S; Albertsson K; Forslind K; van Vollenhoven RF;
    Ann Rheum Dis; 2015 Aug; 74(8):1509-14. PubMed ID: 24706006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data.
    Granger B; Combe B; Le Loet X; Saraux A; Guillemin F; Fautrel B
    RMD Open; 2016; 2(1):e000245. PubMed ID: 27252898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort.
    Durnez A; Vanderschueren G; Lateur L; Westhovens R; Verschueren P
    Ann Rheum Dis; 2011 Apr; 70(4):634-7. PubMed ID: 21177296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.
    Archer R; Hock E; Hamilton J; Stevens J; Essat M; Poku E; Clowes M; Pandor A; Stevenson M
    Health Technol Assess; 2018 Nov; 22(66):1-294. PubMed ID: 30501821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
    Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
    J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
    Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
    Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
    Ellingsen T; Hansen I; Thorsen J; Møller BK; Tarp U; Lottenburger T; Andersen LS; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Lindegaard H; Jacobsen S; Østergaard M; Vestergaard A; Jurik AG; Junker P; Christensen AF; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K
    Scand J Rheumatol; 2014; 43(2):91-100. PubMed ID: 23980529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
    Brahe CH; Østergaard M; Johansen JS; Defranoux N; Wang X; Bolce R; Sasso EH; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll C; Jørgensen A; Krintel SB; Raun J; Hetland ML
    Scand J Rheumatol; 2019 Jan; 48(1):9-16. PubMed ID: 29985080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials.
    Brahe CH; Dehlendorff C; Østergaard M; Johansen JS; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Lindegaard H; Hansen I; Lottenburger T; Jacobsen S; Jurik AG; Hetland ML
    Scand J Rheumatol; 2018 Jul; 47(4):259-269. PubMed ID: 29336711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy.
    Shiozawa K; Yamane T; Murata M; Yoshihara R; Tsumiyama K; Imura S; Shiozawa S
    Arthritis Res Ther; 2016 Feb; 18():55. PubMed ID: 26922083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis.
    Lillegraven S; Paynter N; Prince FH; Shadick NA; Haavardsholm EA; Frits ML; Iannaccone CK; Kvien TK; Weinblatt ME; Solomon DH
    Arthritis Care Res (Hoboken); 2013 Apr; 65(4):526-33. PubMed ID: 23044765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate.
    Weinblatt ME; Keystone EC; Cohen MD; Freundlich B; Li J; Chon Y; Baumgartner SW
    J Rheumatol; 2011 Feb; 38(2):242-6. PubMed ID: 21078715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate.
    Smolen JS; van Vollenhoven RF; Florentinus S; Chen S; Suboticki JL; Kavanaugh A
    Ann Rheum Dis; 2018 Nov; 77(11):1566-1572. PubMed ID: 30076156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.